Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1983 Jul;198(1):102–107. doi: 10.1097/00000658-198307000-00020

Tomographic gallium-67 citrate scanning. Useful new surveillance for metastatic melanoma.

J M Kirkwood, J E Myers, D R Vlock, R Neumann, S Ariyan, A Gottschalk, P Hoffer
PMCID: PMC1352941  PMID: 6859984

Abstract

Conventional gallium scans are not useful to evaluate patients with metastatic melanoma. We evaluated a new method of tomographic gallium imaging. One hundred fourteen tomographic scans were obtained in a prospective surveillance study of 67 patients over a 3-year period. Scans were evaluated and compared to findings of independent clinical evaluations. Sensitivity of gallium identification of tumor involving peripheral lymph nodes and soft tissues, abdomen, mediastinum, and osseous sites was 68% to 100%; overall sensitivity of this technique is 82% with specificity of 99% in 570 organ system assessments. Analysis of discordant findings when a site was clinically occult but gallium-positive showed gallium uptake to be true-positive in six of seven lymphatic sites, three of three lung and mediastinal sites, six of six abdominal sites, but in no brain or bone sites. Gallium lesions identified by computed tomographic scans proved to be false-positive at one lymphatic and one bone site, and false-negative at four otherwise clinically evident lymph node and soft tissue sites, seven pulmonary sites, and four brain sites. Gallium tomographic scanning provides a composite assessment of melanoma and may eliminate the need for other studies.

Full text

PDF
102

Images in this article

104Fig. 1.
on p.104
105Fig. 2.
on p.105
106Fig. 3.
on p.106

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agrup G., Agrup P., Andersson T., Falck B., Hansson J-A, Jacobsson S., Rorsman H., Rosengrem A-M, Rosengren E. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis. Acta Derm Venereol. 1975;55(5):337–341. [PubMed] [Google Scholar]
  2. Aranha G. V., Simmons R. L., Gunnarsson A., Grage T. B., McKhann C. F. The value of preoperative screening procedures in stage I and II malignant melanoma. J Surg Oncol. 1979;11(1):1–6. doi: 10.1002/jso.2930110102. [DOI] [PubMed] [Google Scholar]
  3. Blois M. S., Banda P. W. Detection of occult metastatic melanoma by urine chromatography. Cancer Res. 1976 Sep;36(9 PT1):3317–3323. [PubMed] [Google Scholar]
  4. Cha Y. N., Bueding E. Recovery of the hepatic drug-metabolizing capacity in mice infected with Schistosoma mansoni following curative chemotherapy with the schistosomicide 4-isothiocyano-4'-nitro-diphenylamine (CGP 4540). Am J Trop Med Hyg. 1978 Nov;27(6):1188–1191. doi: 10.4269/ajtmh.1978.27.1188. [DOI] [PubMed] [Google Scholar]
  5. Ernst C. B., Daugherty M. E., Bristow D. L. Supraceliac pseudoaneurysm of abdominal aorta. Staged repair employing preliminary axillary-femoral bypass. Arch Surg. 1975 Feb;110(2):211–214. doi: 10.1001/archsurg.1975.01360080077014. [DOI] [PubMed] [Google Scholar]
  6. Evans R. A., Bland K. I., McMurtrey M. J., Ballantyne A. J. Radionuclide scans not indicated for clinical stage I melanoma. Surg Gynecol Obstet. 1980 Apr;150(4):532–534. [PubMed] [Google Scholar]
  7. Fee H. J., Robinson D. S., Sample W. F., Graham L. S., Holmes E. C., Morton D. L. The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery. 1978 Nov;84(5):626–632. [PubMed] [Google Scholar]
  8. Hauser M. F., Gottschalk A. Comparison of the Anger tomographic scanner and the 15-in. scintillation camera for gallium imaging. J Nucl Med. 1978 Sep;19(9):1074–1077. [PubMed] [Google Scholar]
  9. Hoffer P. B., Gottschalk A. Tumor scanning agents. Semin Nucl Med. 1974 Jul;4(3):305–316. doi: 10.1016/s0001-2998(74)80017-6. [DOI] [PubMed] [Google Scholar]
  10. Hoffer P. B., Huberty J., Khayam-Bashi H. The association of Ga-67 and lactoferrin. J Nucl Med. 1977 Jul;18(7):713–717. [PubMed] [Google Scholar]
  11. Hoffer P. B., Miller-Catchpole R., Turner D. A. Demonstration of lactoferrin in tumor tissue from two patients with positive gallium scans. J Nucl Med. 1979 May;20(5):424–427. [PubMed] [Google Scholar]
  12. Hoffer P. B., Schor R., Ashby D., Metz C., Hattner R., Handmaker H., Price D. C., Shames D. M., Lilien D., Lim C. B. Comparison of Ga-67 citrate images obtained with rectilinear scanner and large-field Anger camera. J Nucl Med. 1977 Jun;18(6):538–541. [PubMed] [Google Scholar]
  13. Jackson F. I., McPherson T. A., Lentle B. C. Gallium-67 scintigraphy in multisystem malignant melanoma. Radiology. 1977 Jan;122(1):163–167. doi: 10.1148/122.1.163. [DOI] [PubMed] [Google Scholar]
  14. Larson S. M., Rasey J. S., Grunbaum Z., Allen D. R. Pharmacologic enhancement of gallium-67 tumor-to-blood ratios for EMT-6 sarcoma (BALB/c mice). Radiology. 1979 Jan;130(1):241–244. doi: 10.1148/130.1.241. [DOI] [PubMed] [Google Scholar]
  15. Lee Y. T. Malignant melanoma: pattern of metastasis. CA Cancer J Clin. 1980 May-Jun;30(3):137–142. doi: 10.3322/canjclin.30.3.137. [DOI] [PubMed] [Google Scholar]
  16. Meyer C. M., Lecklitner M. L., Logic J. R., Balch C. E., Bessey P. Q., Tauxe W. N. Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma. Radiology. 1979 Apr;131(1):205–209. doi: 10.1148/131.1.205. [DOI] [PubMed] [Google Scholar]
  17. Milder M. S., Frankel R. S., Bulkley G. B., Ketcham A. S., Johnston G. S. Gallium-67 scintigraphy in malignant melanoma. Cancer. 1973 Dec;32(6):1350–1356. doi: 10.1002/1097-0142(197312)32:6<1350::aid-cncr2820320611>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  18. Muss H. B., Richards F., 2nd, Barnes P. L., Willard V. V., Cowan R. J. Radionuclide scanning in patients with advanced malignant melanoma. Clin Nucl Med. 1979 Dec;4(12):516–518. [PubMed] [Google Scholar]
  19. Musumeci R., La Monica G., Orefice S., Paolucci R., Petrillo R., Uslenghi C. Lymphographic evaluation of 250 patients with malignant melanoma. Cancer. 1976 Oct;38(4):1568–1573. doi: 10.1002/1097-0142(197610)38:4<1568::aid-cncr2820380420>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  20. Nixon P. F. The urinary melanogen cysteinyldopa in melanoma and in suntanning: Australian experience. Aust N Z J Surg. 1978 Feb;48(1):17–21. doi: 10.1111/j.1445-2197.1978.tb05797.x. [DOI] [PubMed] [Google Scholar]
  21. Pavel S., Matous B., Duchon J. Simple screening test for estimation of some phenolic and indolic compounds in urine application to melanoma. J Invest Dermatol. 1978 Apr;70(4):197–199. doi: 10.1111/1523-1747.ep12541320. [DOI] [PubMed] [Google Scholar]
  22. Romolo J. L., Fisher S. G. Gallium67 scanning compared with physical examination in the preoperative staging of malignant melanoma. Cancer. 1979 Aug;44(2):468–472. doi: 10.1002/1097-0142(197908)44:2<468::aid-cncr2820440214>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  23. Seigler H. F., Fetter B. F. Current management of melanoma. Ann Surg. 1977 Jul;186(1):1–12. doi: 10.1097/00000658-197707000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Voorhess M. L. Urinary excreion of DOPA and metabolites by patients with melanoma. Cancer. 1970 Jul;26(1):146–149. doi: 10.1002/1097-0142(197007)26:1<146::aid-cncr2820260119>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES